Sam Chun Dang Pharm. Co., Ltd (KOSDAQ:000250)
South Korea · Delayed Price · Currency is KRW 261,500
-1,500 (-0.57%)
Jun 12, 2026, 3:30 PM KST
Sam Chun Dang Pharm. Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 10,232 | 5,262 | -10,916 | -10,383 | 5,838 | -16,555 |
Depreciation & Amortization | 11,712 | 10,993 | 9,029 | 8,430 | 7,651 | 6,741 |
Loss (Gain) From Sale of Assets | -471.39 | -441.9 | 105.7 | -295.71 | -798.72 | -41.87 |
Asset Writedown & Restructuring Costs | 50.47 | 50.47 | 62.28 | 1,045 | - | 488.57 |
Loss (Gain) From Sale of Investments | -1,592 | -440.57 | -3,242 | -3,450 | 1,587 | 5,024 |
Stock-Based Compensation | -634.25 | -503.28 | 519.16 | 81.41 | - | - |
Provision & Write-off of Bad Debts | -149.42 | 23.81 | 265.63 | 77.69 | -97.92 | -166.15 |
Other Operating Activities | 8,041 | -7,111 | 24,648 | 27,196 | 9,521 | 14.48 |
Change in Accounts Receivable | -26,750 | 2,864 | -23,531 | 3,209 | -3,470 | -2,351 |
Change in Inventory | -8,756 | -15,824 | -5,071 | -5,753 | -5,287 | -2,282 |
Change in Accounts Payable | 10,071 | 9,471 | 13,225 | -6,300 | -3,690 | 4,588 |
Change in Other Net Operating Assets | -2,883 | 5,448 | 16,675 | 9,569 | 2,027 | -3,166 |
Operating Cash Flow | -1,129 | 9,793 | 21,771 | 23,428 | 13,279 | -7,707 |
Operating Cash Flow Growth | - | -55.02% | -7.07% | 76.43% | - | - |
Capital Expenditures | -51,911 | -46,146 | -17,022 | -6,766 | -16,531 | -14,882 |
Sale of Property, Plant & Equipment | 30.27 | 33.27 | 16.82 | 683.79 | 1,292 | 6.9 |
Sale (Purchase) of Intangibles | -17,493 | -12,739 | -24,279 | -15,208 | -30,015 | -14,425 |
Investment in Securities | 35,158 | 17,624 | 20,869 | 15,452 | -8,350 | -1,719 |
Other Investing Activities | -601.2 | -952.42 | 6.25 | 31.83 | -882.87 | 403 |
Investing Cash Flow | -34,992 | -42,356 | -23,158 | -8,421 | -53,938 | -30,050 |
Short-Term Debt Issued | - | 8,083 | 17,551 | 35,224 | 8,145 | 5,635 |
Long-Term Debt Issued | - | 29,542 | 6,959 | 16,000 | 20,000 | 30,000 |
Total Debt Issued | 36,723 | 37,625 | 24,510 | 51,224 | 28,145 | 35,635 |
Short-Term Debt Repaid | - | -8,589 | -17,487 | -25,754 | -6,969 | -6,066 |
Long-Term Debt Repaid | - | -1,695 | -11,589 | -21,203 | -924.5 | -909.26 |
Total Debt Repaid | -10,026 | -10,284 | -29,076 | -46,957 | -7,893 | -6,976 |
Net Debt Issued (Repaid) | 26,697 | 27,341 | -4,566 | 4,267 | 20,251 | 28,659 |
Issuance of Common Stock | 10,030 | 90.28 | 71,215 | - | - | - |
Repurchase of Common Stock | - | - | - | - | -5,958 | - |
Dividends Paid | - | -4,651 | -890.15 | -880.82 | -968.35 | -968.35 |
Other Financing Activities | - | - | - | -0.1 | - | - |
Financing Cash Flow | 36,726 | 22,779 | 65,759 | 3,387 | 13,325 | 27,691 |
Foreign Exchange Rate Adjustments | 772.68 | 142.61 | 785.12 | -66.66 | 321.18 | 243.95 |
Miscellaneous Cash Flow Adjustments | 0 | - | - | - | - | - |
Net Cash Flow | 1,378 | -9,641 | 65,157 | 18,326 | -27,013 | -9,822 |
Free Cash Flow | -53,040 | -36,353 | 4,748 | 16,662 | -3,252 | -22,589 |
Free Cash Flow Growth | - | - | -71.50% | - | - | - |
Free Cash Flow Margin | -21.56% | -15.68% | 2.25% | 8.65% | -1.83% | -13.50% |
Free Cash Flow Per Share | -2265.67 | -1563.04 | 206.18 | 732.16 | -147.38 | -1023.60 |
Cash Interest Paid | 60.74 | 137.62 | 128.41 | 2,852 | 1,375 | 377.97 |
Cash Income Tax Paid | 7,905 | 21,972 | 2,627 | 1,432 | 2,431 | 3,279 |
Levered Free Cash Flow | -71,801 | -59,320 | -20,510 | -18,623 | -35,043 | -24,647 |
Unlevered Free Cash Flow | -71,226 | -58,708 | -20,271 | -17,012 | -33,297 | -23,462 |
Change in Working Capital | -28,318 | 1,961 | 1,299 | 726.09 | -10,420 | -3,211 |